• +39 055 01 91 395


N.T. Laboratory operates in the IVD Industry with a special focus on new technologies such as Liquid Based Cytology, POC and Molecular Biology. Since 1999 member of the Hospitex Diagnostics srl group as medical devices developer and manufacturer, more recently decided to enter in the IVD market with its own brand.

Being the company competitor in a high-demanding technological sector the staff of 12 workers is highly qualified and composed of experienced figures such as Project Managers, Engineers and Senior mechanical workers to envisage and solve the specific demand coming from the customers’ needs.

N.T offers several solutions for OEM. We offer our capability to deliver high standard products with optimal prices. Every product is certified CE-IVD.

N.T. mission is to make diagnostics instruments that help to detect diseases.

N.T. vision is to become a major player in innovative IVD solutions.

N.T. values are focused on technology edge; bringing to market the latest, most cost-effective diagnostic solutions.

N.T. strategy is to create value for all our stakeholders by accelerating the flow of innovative, new cutting-edge equipments that provide improved outcomes for laboratories throughout the world. Most of the products we sell today were discovered or developed by our own scientists and our success depends to great extent on our ability to continue to discover, develop and bring to market innovative new diagnostic equipments.

Long term goals
N.T. long term goals are reenergizing the pipeline and reinvent R&D

EU projects:

N.T. Laboratory is partner in two collaborative EU projects:N.T. Laboratory is partner in two collaborative EU projects:

FP7-SME-2013-606488 December 2013 - August 2016
Fast, cost-effective, user-friendly point of care (POC) instrument for detection of respiratory pathogens, including Streptococcus pneumoniae

ICT-39-2015-688207 February 2016 - January 2020
Automated diagnostic platform, data management system and innovative communication tool, for improving the impact of malaria vector control interventions